RECORDATI ORD

REC•MIL

Healthcare Italy Drug Manufacturers - General

Need professional-grade analysis? Visit stockanalysis.com

€45.54

+0.71%

End of day

Market Cap

$9.47B

P/E Ratio

N/A

Employees

4,450

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	3.12	-2.75	-1.62	-1.52	-0.73	0.15	-0.81
Calmar	18.61	-5.68	-2.41	-1.44	-0.70	0.07	-0.44
Sharpe	1.60	-2.40	-1.28	-1.16	-0.57	0.10	-0.70
Omega	1.33	0.59	0.79	0.82	0.92	1.04	0.90
Martin	30.40	-10.15	-4.84	-2.66	-1.49	0.15	-1.09
Ulcer	0.76	4.58	5.29	9.04	8.70	17.08	9.54

RECORDATI ORD (REC) Price Performance

RECORDATI ORD (REC) trades on MIL in EUR. The company is classified in the Healthcare sector under the Drug Manufacturers - General industry. The stock currently trades at EUR45.54, up 0.71% from the previous close.

Over the past year, REC has traded between a low of EUR43.65 and a high of EUR54.61. The stock has lost 11.8% over this period. It is currently 16.6% below its 52-week high.

RECORDATI ORD has a market capitalization of $9.47B.

About RECORDATI ORD

Recordati is a leading healthcare company in the drug manufacturers - general industry, specializing in the development and production of life-enhancing and life-changing medicines. Headquartered in Italy, the company has been at the forefront of the pharmaceutical industry for over a century and has been publicly listed on the Italian stock exchange since 1984.

Company Info

Sector: Healthcare
Industry: Drug Manufacturers - General
Exchange: MIL
Currency: EUR
Country: Italy

Financial Metrics

Revenue (TTM): N/A
EBITDA: N/A
Profit Margin: N/A
EPS (TTM): N/A
Book Value: N/A

Technical Indicators

52 Week High: €54.66
52 Week Low: €42.87
50 Day MA: €47.07
200 Day MA: €50.20
Beta: N/A

Valuation

Trailing P/E: N/A
Forward P/E: N/A
Price/Sales: N/A
Price/Book: N/A
Enterprise Value: $9.47B